Similar companies
| Company | Youtube Subscribers | |
|---|---|---|
 |
Johnson & JohnsonJNJ |
73,600 0% |
 |
PfizerPFE |
15 0% |
 |
AstrazenecaAZN |
16,500 0% |
 |
AbbVieABBV |
6,510 0% |
 |
ModernaMRNA |
12,000 0% |
Month over Month
Subscribers on Youtube.
| Sep 2024 | 3,760 | |
| Aug 2024 | 3,730 | |
| Jun 2024 | 3,690 |
How many users are subscribing to Merck & Company on Youtube?
Merck & Company has 3,800 subscribers on Youtube.
Analyzing Youtube Subscribers, how is Merck & Company performing compared to its industry peers?
Merck & Company underperforms its industry peers when it comes to Youtube Subscribers, ranking in the 5th percentile.
How has Merck & Company's Youtube Subscribers changed in the last month?
Merck & Company has experienced a 1.1% increase in YouTube subscribers over the last month, indicating an uptrend in audience engagement and digital presence.
Can the changes in Merck & Company's YouTube subscriber base be linked to its overall brand influence and business success?
With a positive growth and a substantial total of 3,800 Youtube subscribers, Merck & Company's is enhancing its brand recognition and influence on YouTube. This indicates a positive trend in audience engagement, contributing to the company's market presence.
Why is it important to monitor how many users are subscribing to Merck & Company on Youtube?
A growing subscriber base signifies increasing audience engagement, brand strength, and a potential customer base, which is positive news for Merck & Company. On the other hand, a declining number of YouTube subscribers can negatively impact a company's stock performance, signaling waning interest, decreased audience engagement, or a loss of market share. Therefore, monitoring YouTube subscribers is crucial for comprehending a company's online audience, gauging interest levels, and assessing customer perception, all of which can potentially influence the company's future trajectory and stock performance.
Sign up and get more insights on Merck & Company and its Youtube subscribers.
